These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34131867)

  • 21. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A; Ganesh S; Jorgensen D; Tevar A; Ganoza A; Molinari M; Hughes C
    Ann Surg; 2019 Sep; 270(3):444-451. PubMed ID: 31305283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
    Badawy A; Kaido T; Hamaguchi Y; Anazawa T; Yagi S; Fukumitsu K; Kamo N; Okajima H; Uemoto S
    Prog Transplant; 2018 Sep; 28(3):213-219. PubMed ID: 29902957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes.
    Cotter TG; Minhem M; Wang J; Peeraphatdit T; Ayoub F; Pillai A; Hernandez-Alejandro R; di Sabato D; Charlton M
    Liver Transpl; 2021 Jul; 27(7):1019-1031. PubMed ID: 33619854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of 100 patients for living donor liver transplantation.
    Trotter JF; Wachs M; Trouillot T; Steinberg T; Bak T; Everson GT; Kam I
    Liver Transpl; 2000 May; 6(3):290-5. PubMed ID: 10827228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of living donor liver transplantation on long-term cardiometabolic and graft outcomes in cirrhosis due to nonalcoholic steatohepatitis.
    Karnam RS; Azhie A; Yang C; Rogalsky A; Chen S; Xu W; Patel K; Selzner N; Lilly L; Cattral M; Bhat M
    Clin Transplant; 2023 Sep; 37(9):e15008. PubMed ID: 37143204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A; Mizuno S; Kato H; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center.
    Lai JC; Pichardo EM; Emond JC; Brown RS
    Am J Transplant; 2009 Mar; 9(3):586-91. PubMed ID: 19191773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of <20.
    Yanagaki M; Onda S; Furukawa K; Taniai T; Haruki K; Akaoka M; Shirai Y; Matsumoto M; Gocho T; Uwagawa T; Ikegami T
    Transplant Proc; 2023 May; 55(4):898-900. PubMed ID: 37095011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living Donor Liver Transplantation for Acute Liver Failure: Donor Safety and Recipient Outcome.
    Pamecha V; Vagadiya A; Sinha PK; Sandhyav R; Parthasarathy K; Sasturkar S; Mohapatra N; Choudhury A; Maiwal R; Khanna R; Alam S; Pandey CK; Sarin SK
    Liver Transpl; 2019 Sep; 25(9):1408-1421. PubMed ID: 30861306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OPTN/SRTR 2020 Annual Data Report: Kidney.
    Lentine KL; Smith JM; Hart A; Miller J; Skeans MA; Larkin L; Robinson A; Gauntt K; Israni AK; Hirose R; Snyder JJ
    Am J Transplant; 2022 Mar; 22 Suppl 2():21-136. PubMed ID: 35266618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
    Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y; Bugeaud E; Zens T; Rizzari M; Mecit N; Leverson GE; Foley D; Mezrich JD; Kanmaz T; Andaçoğlu OM; D'Alessandro AM; Acarlı KS; Kalayoğlu M; Fernandez LA
    Turk J Med Sci; 2021 Apr; 51(2):610-622. PubMed ID: 33037873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA; Ascher NL; Freise CE; Dodge JL; Roberts JP
    Liver Transpl; 2012 Feb; 18(2):160-5. PubMed ID: 22006378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations.
    Roll GR; Spiro M; Raptis DA; Jalal A; Yan CT; Olthoff KM; Caicedo JC; Lee KW; Yagi S; Cattral MS; Soin AS;
    Clin Transplant; 2022 Oct; 36(10):e14656. PubMed ID: 35340054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.
    Merion RM; Shearon TH; Berg CL; Everhart JE; Abecassis MM; Shaked A; Fisher RA; Trotter JF; Brown RS; Terrault NA; Hayashi PH; Hong JC;
    Ann Surg; 2010 Mar; 251(3):542-9. PubMed ID: 20130466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
    Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
    Braun HJ; Grab JD; Dodge JL; Syed SM; Roll GR; Schwab MP; Liu IH; Glencer AC; Freise CE; Roberts JP; Ascher NL
    Transplantation; 2021 Jun; 105(6):1297-1302. PubMed ID: 33347261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.